Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

Update: 2025-10-03

Description

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR non-small cell lung cancer.

Comments

In Channel

Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit

2025-10-2146:09

LCC in Greek: WCLC 2025 Highlights

2025-10-1054:15

FDA Approval: Maintenance Lurbinectedin for SCLC

2025-10-0737:53

LCC in Arabic: WCLC 2025 Highlights

2025-10-0324:40

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

2025-10-0344:06

Lung Cancer Considered: Targeting EGFR NSCLC

2025-10-0344:06

LCC in Korean: WCLC 2025 Highlights

2025-09-3020:24

IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

2025-09-2645:40

LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan

2025-09-1849:37

LCC in Portuguese: WCLC 2025 Highlights

2025-09-1642:45

LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens

2025-09-1123:02

LCC in Hebrew: WCLC 2025 Highlights

2025-09-1019:47

Live From WCLC 2025: Tuesday Highlights & Meeting Summary

2025-09-0943:49

LCC in Spanish: WCLC 2025 Highlights

2025-09-0940:07

Live From WCLC 2025: Monday Highlights

2025-09-0842:29

LCC in Mandarin: WCLC 2025 Highlights

2025-09-0835:32

Live From WCLC 2025: Sunday Highlights

2025-09-0724:29

"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees

2025-09-0619:07

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

2025-08-2952:17

IASLC - ALK Positive Summit

2025-08-2638:16

00:00

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

#box-pro-ellipsis-176125125481160{-webkit-line-clamp:2;}Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

IASLC

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC